StockData

Nika Pharmaceuticals, Inc (NIKA) stock

NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 0/30
$0.41+0.00 (0.00%)

Close on Oct 16, 2026Market cap $431.19MP/E –Yield –

Nika Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Nika Pharmaceuticals's cash was $2.93K at Jun 30, 2026. For fiscal 2025 it was $1.89K, down 9.3% from the year before. The highest annual figure on record is $19.60K in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.89K-9.3%
FY2024Dec 31, 2024$2.08K-89.4%
FY2023Dec 31, 2023$19.60K+2168.1%
FY2022Dec 31, 2022$864+116.5%
FY2021Dec 31, 2021$399-75.2%
FY2020Dec 31, 2020$1.61K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.93K-81.2%
Q1 FY2026Mar 31, 2026$1.53K-92.0%
Q4 FY2025Dec 31, 2025$1.89K-9.3%
Q3 FY2025Sep 30, 2025$6.29K+353.6%
Q2 FY2025Jun 30, 2025$15.62K-20.3%
Q1 FY2025Mar 31, 2025$19.14K-2.3%
Q4 FY2024Dec 31, 2024$2.08K-80.9%
Q3 FY2024Sep 30, 2024$1.39K-87.5%
Q1 FY2024Mar 31, 2024$19.60K+339.5%
Q4 FY2023Dec 31, 2023$19.60K+2168.1%
Q3 FY2023Sep 30, 2023$10.91K+178.7%
Q2 FY2023Jun 30, 2023$11.05K+29.4%
Q1 FY2023Mar 31, 2023$4.46K+5272.3%
Q4 FY2022Dec 31, 2022$864+116.5%
Q3 FY2022Sep 30, 2022$3.91K+130.4%
Q2 FY2022Jun 30, 2022$8.55K+2047.0%
Q1 FY2022Mar 31, 2022$83-93.9%
Q4 FY2021Dec 31, 2021$399-75.2%
Q3 FY2021Sep 30, 2021$1.70K–
Q2 FY2021Jun 30, 2021$398–
Q1 FY2021Mar 31, 2021$1.36K–
Q4 FY2020Dec 31, 2020$1.61K–

More Nika Pharmaceuticals figures

See a number that looks wrong?